To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Similar improvement in pain and function with triamcinolone and methylprednisolone 40mg for knee OA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2019

Similar improvement in pain and function with triamcinolone and methylprednisolone 40mg for knee OA

Vol: 8| Issue: 4| Number:30| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Efficacy of Triamcinolone Hexacetonide versus Methylprednisolone Acetate Intraarticular Injections in Knee Osteoarthritis: A Randomized, Double-blinded, 24-week Study

J Rheumatol. 2015 Sep;42(9):1677-84. doi: 10.3899/jrheum.150297

Contributing Authors:
CA Zerbini AB Lomonte MG de Morais LO de Carvalho

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

100 patients with Kellgren-Lawrence grade II-III knee osteoarthritis were randomized to a single intraarticular injection of either triamcinolone hexacetonide 40mg or methylprednisolone acetate 40mg. Patients were assessed for outcome after 4, 12, and 24 weeks post-injection. Results for the primary outcome variable of Visual Analog Scale (VAS) pain score demonstrated no significant differences be...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue